Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Boyko

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Epidemiology of neuromyelitis optica spectrum disorder]M A Sherman, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 1, 2022
[A symptom of the central vein in various diseases and protocols of MRI examination]S E Belov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Modern pathogenetic treatment of rare demyelinating diseases]G I Sadekova, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 10, 2023
[Knee range of motion as a marker of the effectiveness of medical intervention in multiple sclerosis]S A Ryabov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 18, 2015
[The results of a randomized open multicenter comparative study on the tolerability and safety of gilenya (fingolimod) in patients with remitting multiple sclerosis]E V Popova, A N Boyko, O V Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2025
[Effect of urolithin A on production of interleukins 6 and 10 by immune cells from patients with MS and healthy donors]A D Kukushkina, V S Rogovsky, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 31, 2018
[Anemia and dysregulation of iron metabolism in multiple sclerosis]A N Belova, V S Solovieva, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Optimal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study]A N Boyko, N Yu Lasch, M E Guseva
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 5, 2023
[The development of multiple sclerosis over the age of 50]N Yu Lashch, A E Pavlikov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 19, 2020
[Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis]I D Stolyarov, A M Petrov, A N Boyko
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Epidemiology of neuromyelitis optica spectrum disorder]M A Sherman, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 1, 2022
[A symptom of the central vein in various diseases and protocols of MRI examination]S E Belov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Modern pathogenetic treatment of rare demyelinating diseases]G I Sadekova, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 10, 2023
[Knee range of motion as a marker of the effectiveness of medical intervention in multiple sclerosis]S A Ryabov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 18, 2015
[The results of a randomized open multicenter comparative study on the tolerability and safety of gilenya (fingolimod) in patients with remitting multiple sclerosis]E V Popova, A N Boyko, O V Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2025
[Effect of urolithin A on production of interleukins 6 and 10 by immune cells from patients with MS and healthy donors]A D Kukushkina, V S Rogovsky, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 31, 2018
[Anemia and dysregulation of iron metabolism in multiple sclerosis]A N Belova, V S Solovieva, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Optimal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study]A N Boyko, N Yu Lasch, M E Guseva
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 5, 2023
[The development of multiple sclerosis over the age of 50]N Yu Lashch, A E Pavlikov, A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 19, 2020
[Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis]I D Stolyarov, A M Petrov, A N Boyko
Pageof 14